Polylactic acid implants (New-Fill)® to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Background In the absence of currently available therapy to manage facial lipoatrophy, strategies used to compensate for facial fat loss warrant clinical evaluation. Methods The goal of this open-label, single-arm, pilot study was to evaluate the efficacy and safety of facial injections of poly-L-lactic acid (PLA) (New-Fill) in HIV-infected patients with severe facial lipoatrophy. Patients received four sets of injection at day 0 and then every 2 weeks for 6 weeks. Patients were evaluated by clinical examination, facial ultrasonography, and photography at screening and at weeks 6, 24, 48, 72, and 96. Results Fifty patients were enrolled. At entry, the median facial fat thickness was equal to zero (range, 0.0-2.1 mm). The median total cutaneous thickness (TCT) increased significantly from baseline : +5.1 mm (range, 2.2-8.6 mm) at week 6, +6.4 mm (range, 3.1-9.1 mm) at week 24, +7.2 mm (range, 4.2-9.6 mm) at week 48, +7.2 mm (range, 3.5-9.6 mm) at week 72 and +6.8 mm (range, 3.9-10.1 mm) at week 96 (P 10 mm was observed in 19% at week 6, 41% at week 24, 61% at week 48, 52% at week 72 and 43% at week 96. In 22 (44%) patients, palpable but non-visible subcutaneous micronodules were observed with a spontaneous resolution in six patients at week 96. Conclusion The benefit of PLA for the correction of the facial lipoatrophy in HIV-infected patients was clearly demonstrated, with an evident aesthetic and quality of life improvement. The efficacy, safety profile, and the simplicity of…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Carr, A., Samaras, K., Burton, S., Law, M., Freund, J., Chisholm, D. J., & Cooper, D. A. (1998) · AIDS · doi:10.1097/00002030-199807000-00003 · Cited by 2,370
Gogolewski, S., Jovanovic, M., Perren, S. M., Dillon, J. G., & Hughes, M. K. (1993) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820270904 · Cited by 547
Martínez, E., Mocroft, A., García-Viejo, M. A., Pérez-Cuevas, J. B., Blanco, J. L., Mallolas, J., Bianchi, L., Conget, I., Blanch, J., Phillips, A., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04056-3 · Cited by 456
Metformin in the Treatment of HIV Lipodystrophy Syndrome: A Randomized Controlled Trial
Hadigan, C., Corcoran, C., Basgoz, N., Davis, B., Sax, P., & Grinspoon, S. (2000) · JAMA · doi:10.1001/jama.284.4.472 · Cited by 357
Carr, A. (2002) · JAMA · doi:10.1001/jama.288.2.207 · Cited by 300 · cited 1×
“Carr [11], we think that this is unlikely to have affected the results of the study.”
ResultDuran, S., Savès, M., Spire, B., Cailleton, V., Sobel, A., Carrieri, P., Salmon, D., Moatti, J.-P., & Leport, C. (2001) · AIDS · doi:10.1097/00002030-200112070-00012 · Cited by 284 · cited 1×
“Treatment-related lipoatrophy has been cited as a reason to delay the initiation of antiretroviral therapy and has been reported to contribute to a reduction in patient adherence to therapy [ 5 ].”
BackgroundBrady, J. M., Cutright, D. E., Miller, R. A., Battistone, G. C., & Hunsuck, E. E. (1973) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820070204 · Cited by 281
Saves, M., Raffi, F., Capeau, J., Rozenbaum, W., Ragnaud, J., Perronne, C., Basdevant, A., Leport, C., Chene, G., & the Antiproteases Cohorte (APROCO) Study Group (2002) · Clinical Infectious Diseases · doi:10.1086/339866 · Cited by 254
Autologous Fat Transplantation: Long‐Term Follow‐Up
PINSKI, K. S., & ROENIGK, H. H. (1992) · The Journal of Dermatologic Surgery and Oncology · doi:10.1111/j.1524-4725.1992.tb02795.x · Cited by 213 · cited 3×
“The durability of autologous fat transplantation depends on several factors, including the harvesting and grafting technique, quality of transplanted tissue, and vascularity of the recipient site [15,16], and the results appear to be highly dependent on the surgeon’s level of training.”
BackgroundResult
Research works printed but not linked: 1
- Kaminer, 2001, Arch Dermatol, 137, 812
Cited by
Farah, S., Anderson, D. G., & Langer, R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.012 · Cited by 3,443
Poly-lactic acid synthesis for application in biomedical devices — A review
Lasprilla, A. J. R., Martinez, G. A. R., Lunelli, B. H., Jardini, A. L., & Filho, R. M. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.06.019 · Cited by 1,174
Current progress on bio-based polymers and their future trends
Babu, R. P., O'Connor, K., & Seeram, R. (2013) · Progress in Biomaterials · doi:10.1186/2194-0517-2-8 · Cited by 1,126
“…PLA/PLGA/ chitosan PLA Drug carrier/drug release Jeevitha and Kanchana 2013; Jayanth and Vinod 2012; Nagarwal et al. 2010; Chandy et al. 2000; Valantin et al. 2003 PLGA and copolymers Degradable sutures Rajev 2000 PLA/HA composites Porous scaffolds for cellular applications Jung-Ju et al.…”
BackgroundGazzard, B., & on behalf of the BHIVA Treatment Guidelines Writing Group (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00636.x · Cited by 1,089
Rajeshkumar, G., Arvindh Seshadri, S., Devnani, G. L., Sanjay, M. R., Siengchin, S., Prakash Maran, J., Al-Dhabi, N. A., Karuppiah, P., Mariadhas, V. A., Sivarajasekar, N., et al. (2021) · Journal of Cleaner Production · doi:10.1016/j.jclepro.2021.127483 · Cited by 640
Metadata
- Authors
- Valantin, M.-A., Aubron-Olivier, C., Ghosn, J., Laglenne, E., Pauchard, M., Schoen, H., Bousquet, R., Katz, P., Costagliola, D., & Katlama, C.
- Affiliations
- Inserm (FR)
- Pitié-Salpêtrière Hospital (FR)
- Corresponding author
- Katlama, Christine
- Venue
- AIDS
- Published
- 2003-11
- Volume
- 17
- Issue
- 17
- Pages
- 2471-2477
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2055099282
- Cited by
- 355
- References
- 18
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 13 · 2023: 8 · 2022: 6 · 2021: 6 · 2020: 5 · 2019: 4 · 2018: 9 · 2017: 6 · 2016: 7 · 2015: 11 · 2014: 10 · 2013: 16 · 2012: 12
- FWCI
- 27.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- AIDS (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Dermatology › Facial Rejuvenation and Surgery Techniques
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Health Sciences › Medicine › Surgery › Body Contouring and Surgery
- Keywords
- poly(L-lactic acid), facial lipoatrophy, HIV infection, facial fat loss, dermal fillers, facial injection, quality of life, aesthetic treatment
- MeSH terms
- Adipose Tissue, Adult, Biocompatible Materials, Drug Implants, Face, Facial Dermatoses, Female, Humans, Injections, Male, Middle Aged, Pilot Projects, Polyesters, Polymers, Quality of Life, Ultrasonography, HIV Infections, Lactic Acid, Antiretroviral Therapy, Highly Active, HIV-Associated Lipodystrophy Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Polylactic acid implants (New-Fill)® to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. https://app.cochat.ai/papers/10.1097/00002030-200311210-00009
- The paper
- Valantin, M.-A., Aubron-Olivier, C., Ghosn, J., Laglenne, E., Pauchard, M., Schoen, H., Bousquet, R., Katz, P., Costagliola, D., & Katlama, C. (2003). Polylactic acid implants (New-Fill)® to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS. https://doi.org/10.1097/00002030-200311210-00009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.